| Literature DB >> 35522469 |
Ponlagrit Kumwichar1, Virasakdi Chongsuvivatwong1, Tagoon Prappre1.
Abstract
BACKGROUND: In Thailand, the health care system has struggled to cope with COVID-19, resulting in directly observed therapy for tuberculosis being de-emphasized. A video-observed therapy (VOT) system, or more specifically, the Thai VOT (TH VOT) system, was developed to replace directly observed therapy. According to the pilot study, the system needed notifications to improve usability and user compliance. The updated version of the TH VOT system thus enabled LINE (Line Corporation) notifications.Entities:
Keywords: app; compliance; digital health; disease monitoring; health care system; health monitoring; infectious disease; lung; online health; remote monitoring; therapy; tuberculosis; usability; user experience; video consultation; video directly observed therapy; video-enhanced therapy; video-observed therapy; virtual therapy
Year: 2022 PMID: 35522469 PMCID: PMC9123535 DOI: 10.2196/35994
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Figure 1A comparison of the previous and improved versions of the TH VOT system. TH VOT: Thai video-observed therapy.
Comparison of this study’s setting and the pilot study’s setting.
|
| Pilot study | This study |
| Sites | Nayong District, Trang Province | Hat Yai and Mueang Songkhla districts, Songkhla Province |
| Centers | 3 primary care units | 19 primary care units |
| Patients | Real patients with tuberculosis who were treated with an isoniazid-rifampicin regimen and had a smartphone or simulated patients who had a smartphone (village health volunteer) | Real patients with tuberculosis who were treated with an isoniazid-rifampicin regimen and had a smartphone or a simulated video-observed therapy system (automatic video sending) |
| Observers | Tuberculosis staff from the primary care units were trained with the original instructions | Tuberculosis staff from the primary care units were trained with the updated instructions |
| Auditor | None | 1 auditor for all |
| Video-observed therapy system | No notification system | LINE notification system added |
| Duration of observation | 14 days | 30 days |
Figure 2Algorithm of the auditor’s judgment.
Participants’ characteristics and their video-observed therapy (VOT) behaviors.
| Characteristics and behaviors | Actual VOT (users: n=20) | Simulated VOT (users: n=9) | |||||||
|
| |||||||||
|
|
| —b | |||||||
|
|
| Female | 4 (40) | — |
| ||||
|
|
| Male | 6 (60) | — |
| ||||
|
| Age (years), median (SD) | 50.6 (13.6) | — | — | |||||
|
| Appointment time, median (minimum, maximum) | 8 PM (7 PM to 9 PM) | 7 PM (7 PM, 7 PM) | — | |||||
|
| Lapse time between video appointment and uploading a video (minutes), median (minimum, maximum) | 230.20 (104.4, 260.9) | 0 (0, 0) | — | |||||
|
|
| <.001 | |||||||
|
|
| Within 1 day | 217 (72) | 270 (100) |
| ||||
|
|
| After midnight | 83 (28) | 0 (0) |
| ||||
|
| Upload time within 1 day, median (minimum, maximum) | 9:01 PM (7:29 PM, 11:59 PM) | 7 PM (7 PM, 7 PM) | — | |||||
|
| Upload time after midnight, median (minimum, maximum) | 1:13 AM (12:02 AM, 2:01 AM) | — | — | |||||
|
| Duration of recording a video (seconds), median (IQR) | 56.3 (47.5-66.4) | 59.6 (50.3-65.8) | .13 | |||||
|
| |||||||||
|
|
| .99 | |||||||
|
|
| Female | 6 (60) | 5 (56) |
| ||||
|
|
| Male | 4 (40) | 4 (44) |
| ||||
|
| Age (years), mean (SD) | 35.9 (4.6) | 39.4 (4.8) | .12 | |||||
|
| Lapse time between video uploading and reviewing (minutes), median (IQR) | 322.6 (156.8-678.1) | 81.9 (71.6-121.3) | .008 | |||||
|
| Review time, median (minimum, maximum) | 3:46 PM (7:42 AM, 10:51 PM) | 8:15 PM (7:02 PM, 10:45 PM) | — | |||||
|
| Duration of reviewing a video (seconds), median (IQR) | 102.7 (89.5-119.5) | 79.4 (70.6-88.9) | <.001 | |||||
aP values were calculated by using a Fisher exact test for all categorical variables, a 2-tailed Student t test for age, and a Wilcoxon rank-sum test for the duration of recording and reviewing.
bNot available.
Average compliance in video-observed therapy (VOT) sessions completed by a user within 30 days (30-day mean cumulative function [MCF]) for each group.
| Participants | Average session compliance of users within 30 days, MCF | Compliance, %a (95% CI) | |
| Patients (n=10) | 21.79 | 72.6 (70.0-75.2) | |
|
| |||
|
| Actual VOT (n=10) | 19.03 | 63.4 (60.6-66.3) |
|
| Simulated VOT (n=9) | 14.65 | 48.8 (44.2-53.5) |
aPercent compliance was calculated as follows: MCF/30 × 100.
Figure 3Visualization of the VOT sessions completed by the three groups of users (solid dots). TB: tuberculosis; VOT: video-observed therapy.
Figure 4The six dimensions of UEQ assessed by the users within 30 days. UEQ: User Experience Questionnaire; VOT: video-observed therapy.